Iambic Therapeutics, Inc. (IAM)
Nasdaq · Biological Products, (No Diagnostic Substances) · Inc. DE
What they're doing
Between 2026-08-02 and 2026-10-31, public records show 1 signal for Iambic Therapeutics, Inc.. Most notable: 2026-10-16: Rachlin Evan Lockwood (director) bought $11.5M of stock. Federal contract obligations over the last 24 months total $0. This summary was assembled automatically from SEC EDGAR, USAspending.gov, U.S. Senate lobbying disclosures and Wikimedia pageview counts.
Generated 2026-10-31 from public records.
Signals, last 12 months
- Insider purchaseRachlin Evan Lockwood (director) bought $11.5M of stock
Insider transactions
| Date | Insider | Role | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-10-16 | Catalio Capital Management, LP; Catalio Nexus Fund III, LP; Catalio Access Fund VIII, LLC; Catalio BH SPV, LLC; Petrocheilos George C | ten percent owner | C | 1,995,749 | — | — |
| 2026-10-16 | Catalio Capital Management, LP; Catalio Nexus Fund III, LP; Catalio Access Fund VIII, LLC; Catalio BH SPV, LLC; Petrocheilos George C | ten percent owner | C | 1,458,290 | — | — |
| 2026-10-16 | Catalio Capital Management, LP; Catalio Nexus Fund III, LP; Catalio Access Fund VIII, LLC; Catalio BH SPV, LLC; Petrocheilos George C | ten percent owner | C | 742,546 | — | — |
| 2026-10-16 | Vogelstein R Jacob | director | C | 1,995,749 | — | — |
| 2026-10-16 | Vogelstein R Jacob | director | C | 1,458,290 | — | — |
| 2026-10-16 | Vogelstein R Jacob | director | C | 742,546 | — | — |
| 2026-10-16 | Secora Michael | officer | C | 61,342 | — | — |
| 2026-10-16 | RASTETTER WILLIAM H | director | C | 192,579 | — | — |
| 2026-10-16 | RASTETTER WILLIAM H | director | C | 8,341 | — | — |
| 2026-10-16 | Rachlin Evan Lockwood | director | C | 1,458,736 | — | — |
| 2026-10-16 | Rachlin Evan Lockwood | director | C | 410,762 | — | — |
| 2026-10-16 | Rachlin Evan Lockwood | director | P | 718,750 | 16 | $11,500,000 |
| 2026-10-16 | Rachlin Evan Lockwood | director | C | 57,754 | — | — |
| 2026-10-14 | Secora Michael | officer | A | 28,400 | 0 | $0 |
| 2026-10-14 | Olson Peter A | officer | A | 19,500 | 0 | $0 |
| 2026-10-14 | Josephson Neil | officer | A | 31,000 | 0 | $0 |
| 2026-10-14 | Manby Frederick R | director | A | 132,200 | 0 | $0 |
| 2026-10-14 | Miller Thomas F. | director | A | 132,200 | 0 | $0 |
Federal contracts
No federal contract actions on record for this recipient mapping.
Lobbying
No federal lobbying filings on record for this client mapping.
Public attention
No Wikipedia pageview data linked to this company.